MNG64
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR12202486 | — | — | 0.911 |
| 2 | SRR8518409 | — | D | 0.876 |
| 3 | TCGA-90-A59Q-01A-11R-A26W-07 | — | cohortA1 | 0.872 |
| 4 | C3N-00433 | — | cohortMD2 | 0.866 |
| 5 | MNG450 | — | — | 0.862 |
| 6 | be8d8236-4ebc-46de-a4fd-a901fec1cdce | — | — | 0.853 |
| 7 | TCGA-MP-A4TJ-01A-51R-A262-07 | — | cohortA1 | 0.851 |
| 8 | SRR8942969 | — | — | 0.850 |
| 9 | DRR168543 | — | — | 0.843 |
| 10 | TCGA-22-1005-01A-01R-0692-07 | — | cohortMD2 | 0.842 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 19 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| INTERFERON_ALPHA_RESPONSE | 0.595 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.545 | Idelalisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.540 | Idelalisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.441 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.300 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.244 | Cobimetinib | — uncovered |
| COMPLEMENT | 0.195 | Inavolisib | — uncovered |
| APICAL_SURFACE | 0.129 | Temsirolimus | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.124 | Inavolisib | — uncovered |
| MYOGENESIS | 0.103 | Inavolisib | — uncovered |
| KRAS_SIGNALING_UP | 0.098 | Inavolisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.093 | Idelalisib | — uncovered |
| COAGULATION | 0.088 | Binimetinib | — uncovered |
| UV_RESPONSE_DN | 0.086 | Inavolisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.084 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.062 | Remibrutinib | — uncovered |
| APOPTOSIS | 0.040 | Idelalisib | — uncovered |
| PEROXISOME | 0.013 | Idelalisib | — uncovered |
| APICAL_JUNCTION | 0.002 | Inavolisib | — uncovered |